| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |